Literature DB >> 2211434

Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance).

K Dornbusch1, G H Miller, R S Hare, K J Shaw.   

Abstract

The incidence of resistance to gentamicin, tobramycin, amikacin and netilmicin was determined by the microdilution method in Mueller-Hinton broth among blood culture isolates consecutively collected in 37 laboratories in 14 European countries. The distribution of bacteria was similar in each laboratory, Escherichia coli and staphylococci predominating. Resistance levels varied between laboratories but they were higher to all four antibiotics in Southern Europe than in Central and Northern Europe. Aminoglycoside resistance was usually associated with production of aminoglycoside-modifying enzymes, ANT(2"), AAC (3)-V, AAC (6')-I predominating in Gram-negative bacilli and APH (2") + AAC (6') and ANT (4')-I in staphylococci.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211434     DOI: 10.1093/jac/26.1.131

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

Review 1.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  F Martineau; F J Picard; N Lansac; C Ménard; P H Roy; M Ouellette; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 4.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 5.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 6.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

7.  Diversity of aminoglycoside resistance in Enterobacter cloacae in Greece.

Authors:  A C Vatopoulos; A Tsakris; L S Tzouvelekis; N J Legakis; T L Pitt; G H Miller; K J Shaw; M Antreou; M Nikolopoulou; Z Komninou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

8.  Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V.

Authors:  M Kresken; D Hafner; H Mittermayer; L Verbist; E Bergogne-Bérézin; H Giamarellou; S Esposito; B van Klingeren; F H Kayser; D S Reeves
Journal:  Infection       Date:  1994       Impact factor: 3.553

9.  Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.

Authors:  A Fernandez-Rodriguez; R Canton; J C Perez-Diaz; J Martinez-Beltran; J J Picazo; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

10.  The role of preoperative antibiotics in the prevention of wound infection after day case surgery for inguinal hernia in children in Ile Ife, Nigeria.

Authors:  U E Usang; O A Sowande; O Adejuyigbe; T I B Bakare; O A Ademuyiwa
Journal:  Pediatr Surg Int       Date:  2008-08-23       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.